Status:
UNKNOWN
Anti-Inflammatory Dietary Intervention for Rheumatoid Arthritis
Lead Sponsor:
Attune Health Research, Inc.
Collaborating Sponsors:
Cedars-Sinai Medical Center
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to assess if there is a significant difference in the mean disease activity score in individuals with RA participating in a dietary intervention compared to thos...
Detailed Description
Per the Schedule of Assessments, upon enrollment, participants will be required to come in for a total of five on site visits. The first visit, also known as the baseline visit, will require participa...
Eligibility Criteria
Inclusion
- Age greater than 18 years.
- Diagnosed RA by a rheumatologist determined by the 2010 ACR/EULAR Classification Criteria.
- Low, moderate, or highly active disease state based on clinical assessment where the investigator feels there is potential to see a difference.
- Able to read and write in English.
Exclusion
- Younger than 18 years.
- Unable to attend the 8 weekly nutrition appointment.
- History of documented eating disorders.
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05291299
Start Date
July 5 2022
End Date
March 1 2025
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Attune Health Research Inc
Beverly Hills, California, United States, 90211